Ranitidine Tablets

Free

Ranitidine Hydrochloride Tablets IP
Each Filmcoated tablet contains :
Ranitidine Hydrochloride IP
Eq. To Ranitidine 150 mg

Ranitidine Hydrochloride Tablets IP
Each Filmcoated tablet contains :
Ranitidine Hydrochloride IP
Eq. To Ranitidine 300 mg

Ranitidine Hydrochloride Tablets USP
Each Filmcoated tablet contains :
Ranitidine Hydrochloride USP
Eq. To Ranitidine 300 mg

Usage: – Indigestion, heartburn and acid reflux, gastro-esophageal reflux disease

Category: – Antacid & Anti ulcer drugs

Therapeutic category: – Antiulcer, Antacid

SKU: Ranitidine Tablets Category: Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Description

Ranitidine Tablets

Healthy Inc is a specialized global supplier and exporter of established gastrointestinal agents. We provide high-purity Ranitidine Tablets, sourced from WHO–GMP certified solid dosage facilities. This “Classic Acid Reducer” is a top export to pharmacy chains, hospital formularies, and government health ministries in Africa, LATAM, and Southeast Asia, serving as a cost-effective, proven therapy for the management of peptic ulcers, GERD, and hypersecretory conditions.


Product Overview

This formulation contains Ranitidine Hydrochloride, a specific, competitive antagonist of histamine H2-receptors.

The “Acid Suppressor” Specialist:

  • Mechanism: Ranitidine reversibly binds to the H2-receptors located on the basolateral membrane of the gastric parietal cells. By blocking histamine (the primary stimulator of acid secretion), it significantly inhibits both basal (fasting) and stimulated gastric acid secretion.
  • Dual Action: It reduces both the volume of acid and the concentration of hydrogen ions, providing relief from heartburn and allowing ulcers to heal.
  • Safety Profile: Unlike Proton Pump Inhibitors (PPIs) which irreversibly block acid pumps, H2 blockers like Ranitidine have a shorter duration of action and a different side effect profile, making them suitable for on-demand relief or maintenance therapy.

Product Composition & Strength

We supply this product as Film Coated Tablets (typically Orange/Pink or White). The coating is essential to mask the bitter taste and ensure stability.

Active IngredientStrength (Standard)Therapeutic Role
Ranitidine HCl IP/BP/USP150 mgStandard Maintenance / Mild Symptoms
Ranitidine HCl IP/BP/USP300 mgAcute Ulcer Healing / Nighttime Relief
ExcipientsQ.S.Microcrystalline Cellulose / HypromelloseFilm Coating

*Pack Sizes: Blister packs of 10s (Box of 10×10), 20s, 30s, or Bulk HDPE Jars of 1000s.


Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.

HS Code3004.90.99 (Other Medicaments)
Dosage FormTablet (Film Coated)
PackagingAlu-Alu Blister or Aluminum Strip
StorageStore below 25°C. Protect from Light and Moisture.
CertificatesWHO-GMP, COPP, Free Sale Certificate

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

  • Impurity Control (NDMA): Following recent regulatory updates regarding NDMA (N-Nitrosodimethylamine) impurities in Ranitidine, our manufacturing partners utilize advanced LC-MS/MS testing to screen every batch. We certify that our product is NDMA-free or strictly within the safe limits defined by international regulatory bodies (USFDA/EMA), ensuring patient safety.
  • Stability: Ranitidine is sensitive to moisture and light. Our formulation includes robust desiccants and light-protective coating agents to prevent degradation (discoloration to brown) in tropical climates.

Therapeutic Indications (Human Use)

Indicated for the treatment of acid-related disorders:

  • Duodenal & Gastric Ulcer: Short-term treatment of active benign ulcers.
  • GERD (Gastroesophageal Reflux Disease): Relief of heartburn and acid regurgitation.
  • Erosive Esophagitis: Healing of erosions caused by acid reflux.
  • Pathological Hypersecretory Conditions: Zollinger-Ellison Syndrome.
  • Stress Ulcer Prophylaxis: Prevention of upper GI bleeding in critically ill patients.

Dosage & Administration

Recommended Dosage (Strictly as per Physician):

  • Route: Oral.
  • Active Ulcer Treatment: 150 mg twice daily OR 300 mg once daily at bedtime for 4-8 weeks.
  • Maintenance Therapy: 150 mg once daily at bedtime.
  • GERD: 150 mg twice daily.
  • Administration: Can be taken with or without food.

Safety Warnings:

  • Renal Impairment: Dosage adjustment is required in patients with kidney disease (Creatinine Clearance < 50 mL/min).
  • Malignancy: Symptomatic response to Ranitidine does not preclude the presence of gastric malignancy. Endoscopy may be indicated.
  • Vitamin B12 Deficiency: Long-term use may impair absorption of Vitamin B12.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for OSD (Oral Solid Dosage) forms, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.

Commercial Inquiries

For hospital tenders, bulk export, or distributor pricing, please contact our export team.

WhatsApp/Call: +91 7710003340
Email: info@healthyinc.co.in